MoonLake Secures up to $500 Million in Non-Dilutive Financing from Hercules Capital and Announces a Capital Markets Update on April 29 to Provide Important Clinical Updates Post date April 3, 2025 ← MoonLake Immunotherapeutics Reports Full Year 2024 Financial Results and Provides a Business Update → MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29